Kees Chamberlain 
Impact of COVID-19 Pandemic on Funding and Reimbursement of Pharmaceuticals and Vaccines
Most European countries have experienced more than one wave of COVID-19 infections. Lockdown and ...
Can “Risk-Sharing” Agreements Enable Fast Access to COVID-19 Vaccines?
As the global COVID-19 pandemic has progressed, so too have efforts to develop, manufacture, ...
